Potential applicants are asked to complete a pre-application following expression of interest in a TACT review. Pre-applications are reviewed by the Chair and Secretariat who assess their suitability.
Full applications are completed via an online system approximately 3-4 months prior to the review meeting. Completing the application focuses the applicant on a number of important considerations including; scientific rationale, the appropriateness and interpretation of the preclinical studies performed; safety and toxicology issues; drug distribution and kinetics; feasibility and cost of drug manufacturing and supply; context of project in the clinical development plan and regulatory consideration critical to advancing a compound into the clinic.
A sample version of the TREAT-NMD Advisory Committee for Therapeutics Application form is available to download. This sample form is intended to be used for reference purposes only and is a static version of the online form which should be used to submit applications.
If you wish to submit an application please contact Cathy Turner for details and access to the online form.
Cathy Turner is Duchenne Programme and TACT Coordinator at the John Walton Muscular Dystrophy Research Centre. Cathy has also been responsible for supporting the NeurOmics project with significant involvement in communications, data-sharing and ethics.